This systematic review highlights consistent associations between increased pro-inflammatory cytokines (i.e., IL-6, IL-1β, TNF-α), reduced levels of hippocampal BDNF, and cognitive impairment in preclinical models of breast cancer and chemotherapy. The gene discussed is BDNF; the disease is Cognitive impairment.